Looking for a breast medical oncology position? Our team is the best!

We have the best team ⁦Cleveland Clinic⁩ !! #BestHospitals ⁦U.S. News & World Report⁩ ranking! See the list of top 5 cancer centers in the country!

COVID-19 pandemic could result in 3,291 to 3,621 additional deaths from breast, colorectal, esophageal, and lung cancers within 5 years: Effect of #COVID19 The Lancet Oncology The Lancet

Hypofractionated Breast Irradiation: What’s Next? ascopubs.org/doi/full/10.12… "Some radiation oncologists may choose to adopt the lower-dose five-fraction regimen, especially in light of the COVID-19 pandemic and the desire to reduce treatment visits" Chirag Shah ASCO Publications

HER2-positive #breastcancer with BMs, the addition of tucatinib +trastuzumab+capecitabine doubled ORR-IC, reduced risk of intracranial progression or death by two thirds, and reduced risk of death by nearly half ASCO Publications #JCO METAvivor MetastaticBCNetwork METUP

Had a lot of fun recording this podcast with Dale Shepard MD, PhD! Looking forward to listening to other episodes of the Cancer Advances podcast Cleveland Clinic MD

Well done @SarahSittenfeld! Your med onc colleagues appreciate knowing this data too!

U.S. Preventive Services Taskforce lowers colorectal cancer screening age to 45! As more young people are developing colorectal cancer, this is a great step. Full recs here: uspreventiveservicestaskforce.org/uspstf/draft-r… #ColonCancer #Cancer

The pandemic has hit the medical community hard. But despite the constant challenges, we as doctors, nurses and medical providers are committed to keeping our communities safe. Please encourage everyone to wash their hands, practice social distancing and wear a mask. #MaskUp

This week in the Cleveland Clinic Cancer Advances podcast, I talk to Cleveland Clinic MD Bhumika Patel About the Cleveland Clinic Cancer Center CHIP Clinic. What is CHIP? Listen to find out what it is and why it’s important. my.clevelandclinic.org/podcasts/cance…

Great start to #SABCS20 oral sessions. Abemaciclib added to endocrine therapy improves IDFS including 31% reduction in distant relapse. #CleClinicCancer

Tamoxifen and anastrozole both remain options for risk reduction after DCIS. Choice should largely be informed by toxicity profiles. #SABCS20 #CleClinicCancer

Exciting results from #SABCS20 for patients with ILC and HER2 mutations!

I hope this is the first of many informative projects to come out of the Great Lakes Breast Cancer Consortium and that this work will help patients with ILC. Thanks to Dr. Steffi Oesterreich Nicole Williams MD for being excellent collaborators! #lobmob #cleclinmd cle.clinic/2JNx8fe

⁦Join Cleveland Clinic MD experts Feb 22 discussing Breast Cancer and Your Genes for those with or at risk for #breastcancer. Stephanie Valente⁩ ⁦Holly Pederson MD⁩ ⁦Risal Djohan⁩ ⁦Zahraa Al-Hilli⁩ ⁦Erin Roesch⁩ ⁦kathleen ashton phd⁩

The NSABP B-60 #clinicaltrial was recently activated. This study is enrolling patients with HER2-positive #breastcancer with residual invasive cancer following neoadjuvant therapy. Dr. Jame Abraham Jame Abraham, MD, FACP of the Cleveland Clinic MD reviews details of the study during #NSABP2021

#ASBrS21 DaniCocco presents Cleveland Clinic data on #invasivelobularcancer Lobular Breast Cancer Alliance Lobular Research

Thanks to our amazing colleagues!! We ⁦Cleveland Clinic⁩ is ranked as #5 best cancer center in the nation!! Deep gratitude to our patients!! We always put patients first!! ⁦U.S. News Health⁩ ⁦Cleveland Clinic MD⁩ #CleClinicCancer

Excited to share the details of our OncLive Institutional Perspectives in Cancer program coming up on September 28! Join us to hear the latest updates in breast cancer from terrific Cleveland Clinic faculty. event.onclive.com/event/34374981… Halle Moore, MD Tiffany Onger, MD Erin Roesch

Such important work highlighting the under-representation of ILC patients in clinical trials and urgent need to have ILC specific results reported. Bravo! Now we need to move the needle on how we evaluate clinical benefit in trials so ILC patients are eligible!